Therapeutic effects of ML-236B in primary hypercholesterolemia
- 31 March 1980
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 35 (3), 259-266
- https://doi.org/10.1016/0021-9150(80)90124-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductaseAtherosclerosis, 1979
- Two Japanese Kindreds of Familial Hypercholesterolemia Including Homozygous Cases. A Report of Cases, and Studies on Serum-Lipoproteins and EnzymesJapanese Journal of Medicine, 1978
- Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemiaAtherosclerosis, 1977
- Needed: New Therapy for HypercholesterolemiaNew England Journal of Medicine, 1977
- Failure of Complete Bile Diversion and Oral Bile Acid Therapy in the Treatment of Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1977
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- THE LOW‐DENSITY LIPOPROTEIN PATHWAY IN HUMAN FIBROBLASTS: RELATION BETWEEN CELL SURFACE RECEPTOR BINDING AND ENDOCYTOSIS OF LOW‐DENSITY LIPOPROTEIN*Annals of the New York Academy of Sciences, 1976
- Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.JCI Insight, 1975
- The metabolism of the apoprotein of plasma low density lipoprotein in familial hype rbetalipoproteinaemia in the homozygous formAtherosclerosis, 1975
- Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cellsJournal of Cellular Physiology, 1975